The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Competing Risk Regression Models for Epidemiologic Data
Open accessAbstract
Competing events can preclude the event of interest from occurring in epidemiologic data and can be analyzed by using extensions of survival analysis methods. In this paper, the authors outline 3 regression approaches for estimating 2 key quantities in competing risks analysis: the cause-specific relative hazard ((cs)RH) and the subdistribution relative hazard ((sd)RH). They compare and contrast the structure of the risk sets and the interpretation of parameters obtained with these methods. They also demonstrate the use of these methods with data from the Women's Interagency HIV Study established in 1993, treating time to initiation of highly active antiretroviral therapy or to clinical disease progression as competing events. In our example, women with an injection drug use history were less likely than those without a history of injection drug use to initiate therapy prior to progression to acquired immunodeficiency syndrome or death by both measures of association ((cs)RH = 0.67, 95% confidence interval: 0.57, 0.80 and (sd)RH = 0.60, 95% confidence interval: 0.50, 0.71). Moreover, the relative hazards for disease progression prior to treatment were elevated ((cs)RH = 1.71, 95% confidence interval: 1.37, 2.13 and (sd)RH = 2.01, 95% confidence interval: 1.62, 2.51). Methods for competing risks should be used by epidemiologists, with the choice of method guided by the scientific question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Statistical Models Based on Counting Processes
Bry, X., Andersen, P. K., Borgan, Ø., Gill, R. D., Keiding, N., & Borgan, O. (1997) · Population (French Edition) · doi:10.2307/1534625 · Cited by 2,884
The Jackknife: The Bootstrap and Other Resampling Plans.
Low, L. Y., & Efron, B. (1983) · Journal of the American Statistical Association · doi:10.2307/2288218 · Cited by 2,702
The Analysis of Failure Times in the Presence of Competing Risks
Prentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Flournoy, N., Farewell, V. T., & Breslow, N. E. (1978) · Biometrics · doi:10.2307/2530374 · Cited by 1,266
Applying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975
The Womenʼs Interagency HIV Study
Barkan, S. E., Melnick, S. L., Preston-Martin, S., Weber, K., Kalish, L. A., Miotti, P., Young, M., Greenblatt, R., Sacks, H., & Feldman, J. (1998) · Epidemiology · doi:10.1097/00001648-199803000-00004 · Cited by 814
A note on competing risks in survival data analysis
Satagopan, J. M., Ben-Porat, L., Berwick, M., Robson, M., Kutler, D., & Auerbach, A. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602102 · Cited by 745
Do We Still Need a Cohort Study of Women with HIV Infection?
&NA; (1998) · Epidemiology · doi:10.1097/00001648-199803000-00001 · Cited by 728
Pepe, M. S., & Mori, M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780120803 · Cited by 620
Crowder, M. J. (2001) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420035902 · Cited by 567
The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench
Bacon, M. C., von Wyl, V., Alden, C., Sharp, G., Robison, E., Hessol, N., Gange, S., Barranday, Y., Holman, S., Weber, K., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.9.1013-1019.2005 · Cited by 520
Self-citationAndrogen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
Tsai, H. K., D'Amico, A. V., Sadetsky, N., Chen, M.-H., & Carroll, P. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm168 · Cited by 520
The Analysis of Exponentially Distributed Life-Times with Two Types of Failure
Cox, D. R. (1959) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1959.tb00349.x · Cited by 485
Gaynor, J. J., Feuer, E. J., Tan, C. C., Wu, D. H., Little, C. R., Straus, D. J., Clarkson, B. D., & Brennan, M. F. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10476289 · Cited by 483
NON-PARAMETRIC INFERENCE FOR CUMULATIVE INCIDENCE FUNCTIONS IN COMPETING RISKS STUDIES
LIN, D. Y. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970430)16:8<901::aid-sim543>3.0.co;2-m · Cited by 445
Competing Risks: A Practical Perspective
Pintilie, M. (2006) · Cited by 443
Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 Infection
Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200107010-00006 · Cited by 350
Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution
Cox, C., Chu, H., Schneider, M. F., & Muñoz, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2836 · Cited by 345
Competing risks as a multi-state model
Andersen, P. K., Abildstrom, S. Z., & Rosthøj, S. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm281ra · Cited by 319
Self-reported Antiretroviral Therapy in Injection Drug Users
Celentano, D. D. (1998) · JAMA · doi:10.1001/jama.280.6.544 · Cited by 258
Methods for estimating the case fatality ratio for a novel, emerging infectious disease
Ghani, A. C., Donnelly, C. A., Cox, D. R., Griffin, J. T., Fraser, C., Lam, T. H., Ho, L. M., Chan, W. S., Anderson, R. M., Hedley, A. J., et al. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi230 · Cited by 252
Xue, Q.-L., Fried, L. P., Glass, T. A., Laffan, A., & Chaves, P. H. M. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm270 · Cited by 245
A Mixture Model for the Regression Analysis of Competing Risks Data
Larson, M. G., & Dinse, G. E. (1985) · Applied Statistics · doi:10.2307/2347464 · Cited by 207
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
Celentano, D. D., Galai, N., Sethi, A. K., Shah, N. G., Strathdee, S. A., Vlahov, D., & Gallant, J. E. (2001) · AIDS · doi:10.1097/00002030-200109070-00015 · Cited by 189
Analysing and interpreting competing risk data
Pintilie, M. (2007) · Statistics in Medicine · doi:10.1002/sim.2655 · Cited by 186
Prediction of Cumulative Incidence Function under the Proportional Hazards Model
Cheng, S. C., Fine, J. P., & Wei, L. J. (1998) · Biometrics · doi:10.2307/2534009 · Cited by 156
Applications of crude incidence curves
Korn, E. L., & Dorey, F. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110611 · Cited by 132
Causal Inference Without Counterfactuals: Comment
Robins, J. M., & Greenland, S. (2000) · Journal of the American Statistical Association · doi:10.2307/2669381 · Cited by 130
Lau, B. M., Gange, S. J., & Moore, R. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000247229.68246.c5 · Cited by 119
Self-citationHessol, N. A., Kalinowski, A. H., Benning, L., Mullen, J., Young, M., Palella, F. J., Anastos, K., Detels, R., & Cohen, M. H. (2006) · Clinical Infectious Diseases · doi:10.1086/510488 · Cited by 94
Keiser, O., Taffé, P., Zwahlen, M., Battegay, M., Bernasconi, E., Weber, R. K., & Rickenbach, M. (2004) · AIDS · doi:10.1097/00002030-200409030-00013 · Cited by 89
Misspecified regression model for the subdistribution hazard of a competing risk
Latouche, A., Boisson, V., Chevret, S., & Porcher, R. (2006) · Statistics in Medicine · doi:10.1002/sim.2600 · Cited by 88
Beyersmann, J., Dettenkofer, M., Bertz, H., & Schumacher, M. C. (2007) · Statistics in Medicine · doi:10.1002/sim.3006 · Cited by 82
Cascade Collaboration (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.5.951 · Cited by 66
Competing Risks and Conditional Probabilities
Chiang, C. L. (1970) · Biometrics · doi:10.2307/2528722 · Cited by 54
Estimation of the Probability of Developing a Disease in the Presence of Competing Risks
Cornfield, J. (1957) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.47.5.601 · Cited by 53
Beyersmann, J., & Schumacher, M. (2006) · Statistics in Medicine · doi:10.1002/sim.2727 · Cited by 41
Evaluating competing adverse and beneficial outcomes using a mixture model
Lau, B. M., Cole, S. R., Moore, R. D., & Gange, S. J. (2008) · Statistics in Medicine · doi:10.1002/sim.3293 · Cited by 24
Self-citationHanley, J. A. (2008) · Epidemiology · doi:10.1097/ede.0b013e31815be045 · Cited by 17
Cited by
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Austin, P. C., Lee, D. S., & Fine, J. P. (2016) · Circulation · doi:10.1161/circulationaha.115.017719 · Cited by 2,653
Practical recommendations for reportingFine‐Gray model analyses for competing risk data
Austin, P. C., & Fine, J. P. (2017) · Statistics in Medicine · doi:10.1002/sim.7501 · Cited by 1,271
Registries for Evaluating Patient Outcomes: A User’s Guide
(2020) · doi:10.23970/ahrqepcregistries4 · Cited by 960
When do we need competing risks methods for survival analysis in nephrology?
Noordzij, M., Leffondre, K., van Stralen, K. J., Zoccali, C., Dekker, F. W., & Jager, K. J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft355 · Cited by 669
Pendlebury, S. T., & Rothwell, P. M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30442-3 · Cited by 620
Metadata
- Authors
- Lau, B., Cole, S. R., & Gange, S. J.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06-03
- Volume
- 170
- Issue
- 2
- Pages
- 244-256
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2154746519
- Cited by
- 1,403
- References
- 43
- FWCI
- 16.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.